Eli Lilly Corp. Stock
Eli Lilly Corp. Stock
A loss of -1.550% shows a downward development for Eli Lilly Corp..
We see a rather positive sentiment for Eli Lilly Corp. with 8 Buy predictions and 2 Sell predictions.
With a target price of €162.00 there is a slightly positive potential of 4.180% for Eli Lilly Corp. compared to the current price of €155.50.
Our community identified positive and negative aspects for Eli Lilly Corp. stock for the coming years. 3 users see the criterium "Business model" as a plus for the Eli Lilly Corp. stock. On the other hand our users think that "Valuation (undervalued/overvalued)" could be a problem in the future.
Pros and Cons of Eli Lilly Corp. in the next few years
Pros
3
Future proof or reliable business model
2
Top 10 in its market
2
Innovative
Cons
1
overvalued
Performance of Eli Lilly Corp. vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | -1.550% | 1.903% | 2.220% | 8.931% | 16.157% | 145.036% | 132.862% |
| Pfizer Inc. | 0.390% | 4.601% | 7.198% | -0.273% | 6.347% | 14.784% | 17.208% |
| Alexion Pharmaceutical Inc. | -0.410% | 4.899% | 7.559% | 43.518% | 6.836% | 47.198% | -1.014% |
| Johnson & Johnson | -0.310% | 0.015% | 0.445% | -3.105% | 7.356% | 30.961% | 37.937% |
Comments
Other discussions about Eli Lilly Corp. Stock
Trading Eli Lilly Corp.
Trading Eli Lilly Corp.
